WeVote

Bill

Bill

SR 347

Jadassohn, Josef; recognize

2025-2026 Regular Session Introduced by Tonya Anderson and 16 co-sponsors

Senate Resolution 347 honors Josef Jadassohn and urges doctors to use patch-testing for patients with metal allergies before orthopedic surgeries, enhancing patient safety.

Senate Read and Referred
0
WeVote Research Nonpartisan
Bill Summary · SR 347

Summary of Senate Resolution 347 (SR 347)

Bill Overview

  • Bill Number: SR 347
  • Title: Recognizing Josef Jadassohn
  • Status: Senate Read and Referred
  • Introduced On: March 4, 2025
  • Classification: Resolution

Purpose and Intent

Senate Resolution 347 aims to honor the contributions of German dermatologist Josef Jadassohn, who developed the patch-testing medical technique in 1895. The resolution encourages medical practitioners to utilize patch-testing for patients with a history of metal hypersensitivity before performing certain implantation surgeries, particularly those involving metal alloys.

Key Provisions

  1. Recognition of Josef Jadassohn: The resolution formally acknowledges Jadassohn's pioneering work in dermatology and the development of patch-testing.

  2. Encouragement for Medical Practitioners:

    • Medical professionals are urged to consider patch-testing for patients with a clinical history of metal hypersensitivity prior to orthopedic implantation operations.
    • The resolution highlights the importance of identifying potential allergic reactions to metals commonly used in implants, such as nickel, cobalt, and chromium.
  3. Collaboration Between Specialists:

    • Surgeons and dermatologists are encouraged to collaborate in establishing guidelines for identifying patients who may benefit from the removal or replacement of previously implanted materials that contain allergens.
  4. Public Awareness:

    • The Secretary of the Senate is tasked with distributing copies of the resolution to the public and press to raise awareness about the importance of patch-testing in preventing allergic complications from metal implants.

Impact

  • Patient Safety: The resolution aims to improve patient outcomes by reducing the risk of allergic reactions and complications associated with metal implants, which can lead to chronic pain, dermatitis, and joint failure.

  • Medical Practice: By promoting patch-testing, the resolution seeks to enhance the standard of care in orthopedic surgery and dermatology, potentially influencing future medical guidelines and practices.

Legislative Timeline

  • March 4, 2025: The resolution was introduced and placed in the Senate hopper.
  • March 6, 2025: The resolution was read in the Senate and referred to the appropriate committee for further consideration.

In summary, SR 347 serves to honor a significant medical figure while advocating for improved practices in the evaluation of patients at risk for metal allergies, ultimately aiming to enhance patient care in orthopedic procedures.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.